AzTrials
AzTrials

Alcohol UseFLOWNCT07910643

FLOW: Influence of the Menstrual Cycle on Alcohol Use in Women

An observational study of Alcohol Use and Alcohol Consumption, run by Hospices Civils de Lyon at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The FLOW study aims to assess the association between menstrual cycle phases and alcohol consumption in women from the general population. Hormonal fluctuations throughout the menstrual cycle may influence alcohol use behaviors, anxiety levels, physical activity, and sleep quality. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Alcohol Use, Alcohol Consumption, Menstrual Cycle
How many people
2,000 participants
Where
1 siteFrance
Study dates
Feb 2027to May 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Women from the general population with regular menstrual cycles.

Who may be able to join

  • Female
  • Age between 18 and 45 years
  • Regular menstrual cycle lasting between 21 and 37 days
  • Able to complete online questionnaires
  • Provides informed consent

Who cannot join

  • Postmenopausal women
  • Use of medications interfering with menstrual cycle physiology, other than contraception
  • Initiation of hormonal contraception within the previous 3 months
  • Pregnant women
  • Breastfeeding women
  • Pregnancy planned within the next 3 month

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Valentine LHORTOLAT, Midwife contact

4 78 86 41 00 ext. +33

valentine.lhortolat@chu-lyon.fr

Benjamin ROLLAND, MD contact

Benjamin.rolland@chu-lyon.fr

France1 site
  • Service Universitaire d'Addictologie de Lyon - Hôpital Lyon Sud - Hospices Civils de Lyon

    Pierre-Bénite, 69495

    Valentine LHORTOLAT, Midwife, 4 78 86 41 00 ext. +33, valentine.lhortolat@chu-lyon.fr

    Valentine LHORTOLAT, Midwife

Other trials in France

About this study

Official title: Influence of the Menstrual Cycle on Alcohol Consumption, Anxiety, Physical Activity and Sleep in Women: A Prospective Longitudinal Observational Cohort Study (FLOW)

The FLOW study aims to assess the association between menstrual cycle phases and alcohol consumption in women from the general population. Hormonal fluctuations throughout the menstrual cycle may influence alcohol use behaviors, anxiety levels, physical activity, and sleep quality. Participants will be followed prospectively for three consecutive menstrual cycles through monthly questionnaires assessing alcohol consumption, anxiety, physical activity, and sleep.

Read the detailed description

Alcohol consumption among women has increased in recent years and represents a major public health concern. Emerging evidence suggests that ovarian hormones may influence vulnerability to substance use and addictive behaviors. The menstrual cycle provides a physiological model to investigate the effects of hormonal fluctuations on alcohol consumption patterns.

FLOW is a prospective, longitudinal, observational cohort study designed to evaluate the relationship between menstrual cycle phases and alcohol consumption in women with regular menstrual cycles. Participants will complete online self-administered questionnaires at baseline (Month 1) and during two subsequent monthly follow-up assessments (Month 2 and Month 3).

Data collected include menstrual cycle characteristics, alcohol use assessed using the Alcohol Timeline Followback (A-TLFB), anxiety symptoms measured by the Generalized Anxiety Disorder-7 scale (GAD-7), physical activity assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF), and sleep quality assessed using the Mini Sleep Questionnaire (MSQ).

Keywords
Menstrual Cycle, Alcohol Consumption, Anxiety, Physical activity, Sleep quality, Contraceptive method
Medical subject headings
Alcohol Drinking, Anxiety Disorders, Motor Activity, Sleep Initiation and Maintenance Disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Occurrence of an alcohol consumption day

    Assessment of whether alcohol was consumed (Yes/No), measured using the Alcohol Timeline Followback (A-TLFB) over the previous 7 days, across three menstrual cycles

    Measured: Up to 3 months

Secondary outcomes (5)
  1. Number of binge drinking days

    Number of days with excessive alcohol consumption during the previous 7 days, assessed using A-TLFB. Excessive alcohol consumption is defined as at least six standard drinks consumed on a given day.

    Measured: Up to 3 months

  2. Association between alcohol consumption and anxiety levels over time

    Correlation between average alcohol consumption and anxiety levels assessed using GAD-7 throughout the menstrual cycle.

    Measured: Up to 3 months

  3. Association between alcohol consumption and physical activity over time

    Correlation between average alcohol consumption and physical activity assessed using IPAQ-SF.

    Measured: Up to 3 months

  4. Association between alcohol consumption and sleep quality over time

    Correlation between average alcohol consumption and sleep quality assessed using the Mini Sleep Questionnaire (MSQ)

    Measured: Up to 3 months

  5. Association between alcohol consumption and contraceptive method

    Comparison of alcohol consumption patterns according to contraceptive method used.

    Measured: Up to 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2026
  2. Study startFeb 2027 (estimated)
  3. Primary completionMay 2027 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
2,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07910643
Sponsor's protocol ID
69HCL26_0226
Acronym
FLOW
Status last verified
Nov 2026
First submitted
27 Oct 2026
Last updated
3 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Alcohol Use and Alcohol Consumption, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Valentine LHORTOLAT, Midwife (4 78 86 41 00 ext. +33, valentine.lhortolat@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Occurrence of an alcohol consumption day (time frame: Up to 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in